AstraZeneca CEO warns of Trump tariffs impact
AstraZeneca's CEO highlights the critical role of the US market amid looming Trump tariffs, emphasising the need for stable trade policies to sustain pharmaceutical innovation.
Category : Search result: AstraZeneca
AstraZeneca shares drop after US legal setback
Pharmaceutical giant AstraZeneca faces a sharp decline in share prices following an unfavourable US court ruling, sparking investor concerns.
AstraZeneca invests $1.5bn in US despite Trump tariff threats
Pharmaceutical giant AstraZeneca announces a bold $1.5bn US expansion despite looming tariff threats from the Trump administration, signalling confidence in transatlantic trade resilience.
Page 1 of 1